Tarsus Pharmaceuticals, Inc. Announces Positive Results of Saturn-1 Pivotal Trial Evaluating TP-03 for the Treatment of Demodex Blepharitis
IRVINE, Calif., June 21, 2021 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), a late clinical-stage biopharmaceutical company whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - June 21, 2021 Category: Pharmaceuticals Source Type: clinical trials
Short-term Effects on Tear Film (Baby Shampoo vs Blephasol)
Condition: Blepharitis Interventions: Other: Blephaclean; Other: Baby Shampoo Sponsor: University of Plymouth Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 26, 2021 Category: Research Source Type: clinical trials